Industry Recommendations on Clinical Added Value of Orphan Drugs
Position Paper of the Joint EBE-EuropaBio Task Force on Rare Diseases and Orphan Medicinal Products (25 November 2009) Industry Recommendations and Suggestions for the Practical Implementation of Policy Principles to Improve Access to Orphan Medicinal Products in the EUDownloads
- Industry Recommendations on Clinical Added Value of Orphan Drugs_25November2009.pdf
(130.739kb) Download